EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination

Caroline De Bouver, Jason Bouziotis, Veerle P W M Wijtvliet, Kevin K Ariën, Joachim Mariën, Leo Heyndrickx, Marie M Couttenye, Hans J W de Fijter, Fabienne Mestrez, Serge Treille, Olivier Mat, Frederic Collart und 8 weitere

Virology Journal · 13.06.2024 · 21 (1)

DOI: 10.1186/s12985-024-02410-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Virology Journal, online erschienen am 13.06.2024. Verfasst von Caroline De Bouver und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19, Immunoglobulin G, Immunoglobulin A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infection with SARS-CoV-2 in high-risk groups such as kidney transplant and dialysis patients is shown to be associated with a more serious course of the disease. Four years after the start of the COVID-19 pandemic, crucial knowledge on the immune responses in these patient groups is still lacking. Therefore, this study aimed at investigating the humoral immune response after a SARS-CoV-2 infection compared to vaccination as well as the evolution of immunoglobulins over time.

Methods

Kidney transplant recipients, patients on haemodialysis or on peritoneal dialysis and healthy controls were included in this longitudinal multicenter study. SARS-CoV-2 anti-RBD, anti-NP and anti-S1S2 immunoglobulin G (IgG) and A (IgA) as well as the neutralizing antibody capacity were measured.

Results

Kidney transplant recipients had a significantly better humoral response to SARS-CoV-2 after infection (86.4%) than after a two-dose mRNA vaccination (55.8%) while seroconversion was comparable in patients on haemodialysis after infection (95.8%) versus vaccination (89.4%). In individuals without prior COVID-19, the IgG levels after vaccination were significantly lower in kidney transplant recipients when compared to all other groups. However, the IgA titres remained the highest in this patient group at each time point, both after infection and vaccination. A history COVID-19 was associated with higher antibody levels after double-dose vaccination in all patient categories and, while decreasing, titres remained high six months after double-dose vaccination.

Conclusion

Kidney transplant recipients had a more robust humoral response to SARS-CoV-2 following infection compared to a two-dose mRNA vaccination, while patients on haemodialysis exhibited comparable seroconversion rates. Notably, individuals with prior COVID-19 exhibited higher IgG levels in response to vaccination. Hybrid immunity is thus the best possible defence against severe COVID-19 disease and seems also to hold up for these populations. Next, it is not clear whether the higher IgA levels in the kidney transplant recipients is beneficial for neutralizing SARS-CoV-2 or if it is a sign of disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCOVID-19Immunoglobulin GImmunoglobulin AAntibodies, ViralSARS-CoV-2Immunity, HumoralRenal DialysisTransplant RecipientsAntibodies, NeutralizingVaccinationCOVID-19 VaccinesHumansMaleFemaleMiddle AgedAgedAdultLongitudinal StudiesSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID-19DialysisImmune responseKidney transplantationSARS-CoV-2 vaccination

Substanzen

Immunoglobulin GImmunoglobulin AAntibodies, ViralAntibodies, NeutralizingCOVID-19 VaccinesSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Laboratory of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
  • Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, Edegem, Belgium.
  • Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.
  • Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Department of Nephrology-Dialysis, University Hospital (CHU) Ambroise Paré, Mons, Belgium.

Zitieren

APA

De Bouver, C., Bouziotis, J., Wijtvliet, V. P. W. M., Ariën, K. K., Mariën, J., Heyndrickx, L., Couttenye, M. M., de Fijter, H. J. W., Mestrez, F., Treille, S., Mat, O., Collart, F., Allard, S. D., Vingerhoets, L., Moons, P., Abramowicz, D., De Winter, B. Y., Pipeleers, L., Wissing, K. M., & Ledeganck, K. J. (2024). Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination. Virology Journal, 21(1). https://doi.org/10.1186/s12985-024-02410-1

Vancouver

De Bouver C, Bouziotis J, Wijtvliet VPWM, Ariën KK, Mariën J, Heyndrickx L, et al. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination. Virology Journal. 2024;21(1). doi:10.1186/s12985-024-02410-1

BibTeX
@article{DeBouver2024,
  author = {De Bouver, Caroline and Bouziotis, Jason and Wijtvliet, Veerle P W M and Ariën, Kevin K and Mariën, Joachim and Heyndrickx, Leo and Couttenye, Marie M and de Fijter, Hans J W and Mestrez, Fabienne and Treille, Serge and Mat, Olivier and Collart, Frederic and Allard, Sabine D and Vingerhoets, Lies and Moons, Pieter and Abramowicz, Daniel and De Winter, Benedicte Y and Pipeleers, Lissa and Wissing, Karl Martin and Ledeganck, Kristien J},
  title = {Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination},
  journal = {Virology Journal},
  year = {2024},
  volume = {21},
  number = {1},
  doi = {10.1186/s12985-024-02410-1}
}
Kostenlos starten →